These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 33129344)

  • 1. α-Secretase nonsense mutation (ADAM10 Tyr167*) in familial Alzheimer's disease.
    Agüero P; Sainz MJ; García-Ayllón MS; Sáez-Valero J; Téllez R; Guerrero-López R; Pérez-Pérez J; Jiménez-Escrig A; Gómez-Tortosa E
    Alzheimers Res Ther; 2020 Oct; 12(1):139. PubMed ID: 33129344
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Agüero-Rabes P; Pérez-Pérez J; Cremades-Jimeno L; García-Ayllón MS; Gea-González A; Sainz MJ; Mahillo-Fernández I; Téllez R; Cárdaba B; Sáez-Valero J; Gómez-Tortosa E
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloid precursor protein glycosylation is altered in the brain of patients with Alzheimer's disease.
    Boix CP; Lopez-Font I; Cuchillo-Ibañez I; Sáez-Valero J
    Alzheimers Res Ther; 2020 Aug; 12(1):96. PubMed ID: 32787955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levels of ADAM10 are reduced in Alzheimer's disease CSF.
    Sogorb-Esteve A; García-Ayllón MS; Gobom J; Alom J; Zetterberg H; Blennow K; Sáez-Valero J
    J Neuroinflammation; 2018 Jul; 15(1):213. PubMed ID: 30045733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [alpha]-Secretase ADAM10 as well as [alpha]APPs is reduced in platelets and CSF of Alzheimer disease patients.
    Colciaghi F; Borroni B; Pastorino L; Marcello E; Zimmermann M; Cattabeni F; Padovani A; Di Luca M
    Mol Med; 2002 Feb; 8(2):67-74. PubMed ID: 12080182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of plasma β-secretase (BACE1) activity and soluble amyloid precursor proteins as potential biomarkers for Alzheimer's disease.
    Wu G; Sankaranarayanan S; Wong J; Tugusheva K; Michener MS; Shi X; Cook JJ; Simon AJ; Savage MJ
    J Neurosci Res; 2012 Dec; 90(12):2247-58. PubMed ID: 22987781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ADAM10 as a biomarker for Alzheimer's disease: A systematic review.
    Oliveira Monteiro E Pereira de Almeida MP; Valle Pedroso R; Mantellatto Grigoli M; Vicente Silva T; Manzine PR; Cominetti MR
    Rev Neurol (Paris); 2024; 180(1-2):1-11. PubMed ID: 37460331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The transmembrane domain of the amyloid precursor protein is required for antiamyloidogenic processing by α-secretase ADAM10.
    Hitschler L; Lang T
    J Biol Chem; 2022 Jun; 298(6):101911. PubMed ID: 35398353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic association between APP, ADAM10 gene polymorphism, and sporadic Alzheimer's disease in the Chinese population.
    Zeng F; Shen C; Liu YH; Li J; Zhu J; Wang YR; Yan JC; Gao CY; Zhou HD; Deng J; Wang YJ
    Neurotox Res; 2015 Apr; 27(3):284-91. PubMed ID: 25631235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential late-onset Alzheimer's disease-associated mutations in the ADAM10 gene attenuate {alpha}-secretase activity.
    Kim M; Suh J; Romano D; Truong MH; Mullin K; Hooli B; Norton D; Tesco G; Elliott K; Wagner SL; Moir RD; Becker KD; Tanzi RE
    Hum Mol Genet; 2009 Oct; 18(20):3987-96. PubMed ID: 19608551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GDE2-RECK controls ADAM10 α-secretase-mediated cleavage of amyloid precursor protein.
    Nakamura M; Li Y; Choi BR; Matas-Rico E; Troncoso J; Takahashi C; Sockanathan S
    Sci Transl Med; 2021 Mar; 13(585):. PubMed ID: 33731436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CNS amyloid-β, soluble APP-α and -β kinetics during BACE inhibition.
    Dobrowolska JA; Michener MS; Wu G; Patterson BW; Chott R; Ovod V; Pyatkivskyy Y; Wildsmith KR; Kasten T; Mathers P; Dancho M; Lennox C; Smith BE; Gilberto D; McLoughlin D; Holder DJ; Stamford AW; Yarasheski KE; Kennedy ME; Savage MJ; Bateman RJ
    J Neurosci; 2014 Jun; 34(24):8336-46. PubMed ID: 24920637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteolytic cleavage of amyloid precursor protein by ADAM10 mediates proliferation and migration in breast cancer.
    Tsang JYS; Lee MA; Chan TH; Li J; Ni YB; Shao Y; Chan SK; Cheungc SY; Lau KF; Tse GMK
    EBioMedicine; 2018 Dec; 38():89-99. PubMed ID: 30470613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting ADAM10 to lipid rafts in neuroblastoma SH-SY5Y cells impairs amyloidogenic processing of the amyloid precursor protein.
    Harris B; Pereira I; Parkin E
    Brain Res; 2009 Nov; 1296():203-15. PubMed ID: 19679113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gallic acid is a dual α/β-secretase modulator that reverses cognitive impairment and remediates pathology in Alzheimer mice.
    Mori T; Koyama N; Yokoo T; Segawa T; Maeda M; Sawmiller D; Tan J; Town T
    J Biol Chem; 2020 Nov; 295(48):16251-16266. PubMed ID: 32913125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyloid precursor protein (APP) processing genes and cerebrospinal fluid APP cleavage product levels in Alzheimer's disease.
    Bekris LM; Galloway NM; Millard S; Lockhart D; Li G; Galasko DR; Farlow MR; Clark CM; Quinn JF; Kaye JA; Schellenberg GD; Leverenz JB; Seubert P; Tsuang DW; Peskind ER; Yu CE
    Neurobiol Aging; 2011 Mar; 32(3):556.e13-23. PubMed ID: 21196064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble amyloid precursor protein α and β in CSF in Alzheimer's disease.
    Brinkmalm G; Brinkmalm A; Bourgeois P; Persson R; Hansson O; Portelius E; Mercken M; Andreasson U; Parent S; Lipari F; Ohrfelt A; Bjerke M; Minthon L; Zetterberg H; Blennow K; Nutu M
    Brain Res; 2013 Jun; 1513():117-26. PubMed ID: 23541617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ADAM10 expression and promoter haplotype in Alzheimer's disease.
    Bekris LM; Lutz F; Li G; Galasko DR; Farlow MR; Quinn JF; Kaye JA; Leverenz JB; Tsuang DW; Montine TJ; Peskind ER; Yu CE
    Neurobiol Aging; 2012 Sep; 33(9):2229.e1-2229.e9. PubMed ID: 22572541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of peroxisome proliferator-activated receptor α stimulates ADAM10-mediated proteolysis of APP.
    Corbett GT; Gonzalez FJ; Pahan K
    Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8445-50. PubMed ID: 26080426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and neurobiological correlates of soluble amyloid precursor proteins in the cerebrospinal fluid.
    Alexopoulos P; Tsolakidou A; Roselli F; Arnold A; Grimmer T; Westerteicher C; Leante MR; Förstl H; Livrea P; Kurz A; Perneczky R
    Alzheimers Dement; 2012 Jul; 8(4):304-11. PubMed ID: 22055653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.